SLC5A2 and cancer: Due to significant clinical and methodological heterogeneity observed across the included studies, which varied in terms of patient populations, cancer types, SGLT2 inhibitor regimens, and outcome definitions, a narrative synthesis approach was deemed most appropriate for this systematic review.